COIN Coinbase Global | $235.38
-8.3% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $350.00 -> $350.00 | High | View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 2/21/2025 |
ORIC ORIC Pharmaceuticals | $7.68
+2.8% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/21/2025 |
SWTX SpringWorks Therapeutics | $58.29
-2.7% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $74.00 -> $74.00 | Medium | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/21/2025 |
VERI Veritone | $2.85
-3.1% | 2/21/2025 | Initiated by | HC Wainwright | - | Buy | | Low | View details for HC Wainwright rating of Veritone (NASDAQ:VERI) on 2/21/2025 |
PRTA Prothena | $15.56
+2.0% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $48.00 -> $48.00 | High | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 2/21/2025 |
INSM Insmed | $81.06
-3.0% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $90.00 -> $90.00 | High | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 2/21/2025 |
NBIX Neurocrine Biosciences | $120.69
+3.9% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $185.00 -> $185.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/21/2025 |
AG First Majestic Silver | $5.55
-3.7% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 2/21/2025 |
FUFU BitFuFu | $5.35
+10.8% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 2/21/2025 |
DVAX Dynavax Technologies | $13.33
| 2/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $31.00 -> $31.00 | Low | View details for HC Wainwright rating of Dynavax Technologies (NASDAQ:DVAX) on 2/21/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
IMUX Immunic | $1.26
+6.6% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 2/21/2025 |
BNTC Benitec Biopharma | $11.30
-2.3% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 2/21/2025 |
RGEN Repligen | $158.99
-2.3% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $180.00 -> $180.00 | Medium | View details for HC Wainwright rating of Repligen (NASDAQ:RGEN) on 2/21/2025 |
ARDX Ardelyx | $5.06
-11.6% | 2/21/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | $5.50 -> $5.50 | High | View details for HC Wainwright rating of Ardelyx (NASDAQ:ARDX) on 2/21/2025 |
FGEN FibroGen | $0.71
-8.6% | 2/20/2025 | Reiterated by | HC Wainwright | Analyst M. Keller | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 2/20/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 2/20/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $190.00 -> $200.00 | Medium | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/20/2025 |
KPTI Karyopharm Therapeutics | $0.60
-1.9% | 2/20/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 2/20/2025 |
LFWD ReWalk Robotics | $1.77
-4.1% | 2/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 2/20/2025 |
HRMY Harmony Biosciences | $34.56
-0.9% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 2/19/2025 |
DRUG Bright Minds Biosciences | $35.99
-0.4% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $85.00 -> $85.00 | High | View details for HC Wainwright rating of Bright Minds Biosciences (NASDAQ:DRUG) on 2/19/2025 |
PHIO Phio Pharmaceuticals | $1.67
-2.9% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 2/19/2025 |
DTIL Precision BioSciences | $5.91
+0.3% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 2/19/2025 |
KRYS Krystal Biotech | $187.86
+2.9% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $221.00 -> $221.00 | High | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 2/19/2025 |
VYNE VYNE Therapeutics | $2.74
+1.5% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.75 -> $5.75 | Low | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 2/19/2025 |
DRD DRDGOLD | $11.05
-5.1% | 2/19/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $17.25 -> $16.25 | Medium | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 2/19/2025 |
SAND Sandstorm Gold | $5.99
-3.3% | 2/19/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $12.00 -> $11.50 | High | View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 2/19/2025 |
VALN Valneva | $7.44
-5.9% | 2/19/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $18.00 -> $17.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 2/19/2025 |
IRD Opus Genetics | $1.09
-1.8% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 2/19/2025 |
HALO Halozyme Therapeutics | $57.75
+0.5% | 2/19/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $70.00 -> $72.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 2/19/2025 |
ABEO Abeona Therapeutics | $5.78
-0.7% | 2/19/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 2/19/2025 |
CMRX Chimerix | $5.16
-0.1% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 2/18/2025 |
STOK Stoke Therapeutics | $8.33
-4.7% | 2/18/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $35.00 -> $47.00 | High | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 2/18/2025 |
RCUS Arcus Biosciences | $11.06
+3.0% | 2/18/2025 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $20.00 -> $18.00 | High | View details for HC Wainwright rating of Arcus Biosciences (NYSE:RCUS) on 2/18/2025 |
ANIX Anixa Biosciences | $3.08
-2.8% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 2/18/2025 |
CABA Cabaletta Bio | $2.05
-2.2% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 2/18/2025 |
LPTH LightPath Technologies | $2.44
-3.6% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 2/18/2025 |
WRN Western Copper & Gold | $1.07
+1.9% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.25 -> $4.25 | High | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 2/18/2025 |
BLCO Bausch + Lomb | $15.75
-0.9% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $23.00 -> $23.00 | Low | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 2/18/2025 |
OTLK Outlook Therapeutics | $1.56
-4.9% | 2/18/2025 | Target Lowered by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $30.00 -> $3.00 | High | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/18/2025 |
GRCE Grace Therapeutics | $3.29
-2.9% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Grace Therapeutics (NASDAQ:GRCE) on 2/18/2025 |
Grab This Altcoin Before Trump's Crypto Announcement (Ad) Grab This Altcoin Before Trump's Crypto Announcement
Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
 Click here to check it out now |
CRBP Corbus Pharmaceuticals | $8.18
-1.2% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 2/18/2025 |
AVXL Anavex Life Sciences | $8.35
-3.8% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | Medium | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/18/2025 |
VNDA Vanda Pharmaceuticals | $4.43
-1.3% | 2/18/2025 | Target Raised by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $20.00 | Low | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 2/18/2025 |
TYRA Tyra Biosciences | $13.17
+3.1% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 2/18/2025 |
OKYO OKYO Pharma | $1.12
+2.3% | 2/18/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 2/18/2025 |
ARCT Arcturus Therapeutics | $17.77
+5.0% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $63.00 -> $63.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 2/14/2025 |
HL Hecla Mining | $5.23
-7.2% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.50 -> $11.50 | High | View details for HC Wainwright rating of Hecla Mining (NYSE:HL) on 2/14/2025 |
ELVA Electrovaya | $2.29
-4.2% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Electrovaya (NASDAQ:ELVA) on 2/14/2025 |
BPMC Blueprint Medicines | $92.25
-2.2% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $135.00 -> $135.00 | Low | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 2/14/2025 |
EOLS Evolus | $13.99
-4.3% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | Medium | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 2/14/2025 |
NMRA Neumora Therapeutics | $1.80
+5.3% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 2/14/2025 |
RARE Ultragenyx Pharmaceutical | $42.59
-4.2% | 2/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $95.00 -> $95.00 | High | View details for HC Wainwright rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/14/2025 |
PTN Palatin Technologies | $1.00
-2.0% | 2/13/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $17.00 -> $7.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 2/13/2025 |
RZLT Rezolute | $4.53
-2.2% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $14.00 -> $14.00 | Low | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 2/13/2025 |
BBIO BridgeBio Pharma | $36.85
+0.1% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $49.00 -> $49.00 | High | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 2/13/2025 |
BIIB Biogen | $140.64
+2.6% | 2/13/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $300.00 -> $241.00 | High | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 2/13/2025 |
ARWR Arrowhead Pharmaceuticals | $19.90
-5.1% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | Medium | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/12/2025 |
HIVE HIVE Digital Technologies | $2.49
-7.4% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $8.00 -> $10.00 | Medium | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 2/13/2025 |
IREN Iris Energy | $10.88
-12.0% | 2/13/2025 | Target Raised by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $16.00 -> $22.00 | High | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 2/13/2025 |
CRSP CRISPR Therapeutics | $47.91
-5.0% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $65.00 -> $65.00 | Low | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/13/2025 |
REPL Replimune Group | $13.98
-2.3% | 2/13/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $22.00 | High | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 2/13/2025 |
APLS Apellis Pharmaceuticals | $27.52
-2.9% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 2/13/2025 |
FBLG FibroBiologics | $1.13
-9.3% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
MLYS Mineralys Therapeutics | $9.56
+0.3% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 2/13/2025 |
OCGN Ocugen | $0.68
-2.9% | 2/13/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $8.00 | High | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 2/13/2025 |
KALA KALA BIO | $6.64
-2.9% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 2/13/2025 |
CMPS COMPASS Pathways | $4.21
-7.3% | 2/13/2025 | Target Lowered by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $45.00 | High | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 2/13/2025 |
CYBN Cybin | $9.09
-2.6% | 2/13/2025 | Target Lowered by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $190.00 -> $150.00 | Medium | View details for HC Wainwright rating of Cybin (NYSE:CYBN) on 2/13/2025 |
EXEL Exelixis | $36.85
+5.0% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 2/13/2025 |
ATAI Atai Life Sciences | $1.99
-2.5% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 2/13/2025 |
SRPT Sarepta Therapeutics | $106.28
-2.0% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/13/2025 |
ALKS Alkermes | $35.33
-0.5% | 2/13/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Neutral -> Neutral | $46.00 -> $46.00 | High | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 2/13/2025 |
CLMT Calumet Specialty Products Partners | $14.92
-3.8% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $33.00 -> $33.00 | High | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 2/12/2025 |
APTO Aptose Biosciences | $0.16
-14.7% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 2/12/2025 |
LGO Largo | $1.76
-3.8% | 2/12/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.20 -> $3.70 | High | View details for HC Wainwright rating of Largo (NYSE:LGO) on 2/12/2025 |
OESX Orion Energy Systems | $0.90
+1.1% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Orion Energy Systems (NASDAQ:OESX) on 2/12/2025 |
TYGO Tigo Energy | $0.96
-2.1% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Tigo Energy (NASDAQ:TYGO) on 2/12/2025 |
COIN Coinbase Global | $235.38
-8.3% | 2/12/2025 | Target Raised by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $255.00 -> $330.00 | Medium | View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 2/12/2025 |
RICK RCI Hospitality | $52.07
-2.8% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $98.00 -> $98.00 | High | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 2/12/2025 |
YTRA Yatra Online | $1.01
| 2/12/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $3.00 | High | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 2/12/2025 |
SAGE Sage Therapeutics | $7.31
+2.2% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Neutral -> Neutral | $14.00 -> $12.00 | Low | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 2/12/2025 |
RLYB Rallybio | $0.75
-2.1% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 2/12/2025 |
INAB IN8bio | $0.27
-5.1% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 2/12/2025 |
SWTX SpringWorks Therapeutics | $58.29
-2.7% | 2/12/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $74.00 -> $74.00 | Medium | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/12/2025 |
IKT Inhibikase Therapeutics | $2.97
-8.9% | 2/12/2025 | Downgraded by | HC Wainwright | Analyst Edward White | Buy -> Neutral | | Low | View details for HC Wainwright rating of Inhibikase Therapeutics (NYSE:IKT) on 2/12/2025 |
URG Ur-Energy | $0.94
-1.6% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.70 -> $2.70 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 2/11/2025 |
FEMY Femasys | $1.65
-7.1% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 2/11/2025 |
GLSI Greenwich LifeSciences | $11.95
-0.7% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $38.00 -> $38.00 | Medium | View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 2/11/2025 |
ROIV Roivant Sciences | $10.68
-0.4% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 2/11/2025 |
LCTX Lineage Cell Therapeutics | $0.68
-2.5% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
MITK Mitek Systems | $9.31
+0.9% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 2/11/2025 |
ESPR Esperion Therapeutics | $1.83
-1.4% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 2/11/2025 |
PVLA Palvella Therapeutics | $19.22
+1.2% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 2/11/2025 |
ENTA Enanta Pharmaceuticals | $8.03
-4.2% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 2/11/2025 |
ORIC ORIC Pharmaceuticals | $7.68
+2.8% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/11/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $190.00 -> $190.00 | Medium | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/11/2025 |
VRTX Vertex Pharmaceuticals | $484.24
+0.8% | 2/11/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $550.00 -> $550.00 | High | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/11/2025 |
OKYO OKYO Pharma | $1.12
+2.3% | 2/10/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 2/10/2025 |
IMMX Immix Biopharma | $1.76
-1.1% | 2/10/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 2/10/2025 |
SRTS Sensus Healthcare | $5.38
-3.2% | 2/10/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $11.00 -> $12.00 | Low | View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 2/10/2025 |
CRBP Corbus Pharmaceuticals | $8.18
-1.2% | 2/10/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $80.00 -> $75.00 | High | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 2/10/2025 |
FDMT 4D Molecular Therapeutics | $4.64
-0.6% | 2/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 2/10/2025 |
PLRX Pliant Therapeutics | $3.08
+2.3% | 2/10/2025 | Downgraded by | HC Wainwright | Analyst Ed Arce | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 2/10/2025 |
XPL Solitario Resources | $0.68
-5.7% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.20 -> $1.20 | N/A | View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 2/7/2025 |
IMVT Immunovant | $21.26
+4.0% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $51.00 -> $51.00 | Low | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 2/7/2025 |
NBIX Neurocrine Biosciences | $120.69
+3.9% | 2/7/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $190.00 -> $185.00 | High | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/7/2025 |
PTN Palatin Technologies | $1.00
-2.0% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 2/7/2025 |
EVTL Vertical Aerospace | $4.66
-6.7% | 2/7/2025 | Initiated by | HC Wainwright | Analyst Amit Dayal | Buy | $12.00 | High | View details for HC Wainwright rating of Vertical Aerospace (NYSE:EVTL) on 2/7/2025 |
ALMS Alumis | $5.17
+0.8% | 2/7/2025 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $26.00 -> $19.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 2/7/2025 |
RANI Rani Therapeutics | $1.66
-4.0% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 2/7/2025 |
ORKA Oruka Therapeutics | $11.02
-2.3% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | High | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 2/7/2025 |
GNFT Genfit | $3.81
-2.9% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $13.00 -> $13.00 | Low | View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 2/7/2025 |
XFOR X4 Pharmaceuticals | $0.47
-1.3% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $1.50 | Low | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 2/7/2025 |
CORT Corcept Therapeutics | $63.54
-2.4% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $80.00 -> $80.00 | Medium | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 2/7/2025 |
PTGX Protagonist Therapeutics | $38.75
+0.7% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/7/2025 |
CLSK CleanSpark | $9.25
-8.1% | 2/7/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 2/7/2025 |
IPHA Innate Pharma | $2.24
-0.9% | 2/6/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.50 -> $11.50 | Medium | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 2/6/2025 |
VKTX Viking Therapeutics | $34.07
+7.7% | 2/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 2/6/2025 |
KURA Kura Oncology | $8.25
+1.2% | 2/6/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $40.00 | High | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 2/6/2025 |
HROW Harrow | $28.95
-3.9% | 2/6/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy | $57.00 | Medium | View details for HC Wainwright rating of Harrow (NASDAQ:HROW) on 2/6/2025 |
EXOD Exodus Movement | $47.81
+0.0% | 2/5/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Exodus Movement (NYSEAMERICAN:EXOD) on 2/5/2025 |
ALT Altimmune | $6.43
-3.0% | 2/5/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 2/5/2025 |
ACET Adicet Bio | $0.97
-2.7% | 2/5/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | High | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 2/5/2025 |
GROY Gold Royalty | $1.41
-2.8% | 2/5/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $5.50 -> $5.75 | High | View details for HC Wainwright rating of Gold Royalty (NYSE:GROY) on 2/5/2025 |
RZLT Rezolute | $4.53
-2.2% | 2/5/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $14.00 -> $14.00 | Low | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 2/5/2025 |
USGO U.S. GoldMining | $11.68
-0.8% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $26.50 -> $26.50 | High | View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 2/4/2025 |
GEVO Gevo | $1.52
-6.2% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 2/4/2025 |
NAK Northern Dynasty Minerals | $0.65
-5.7% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.30 -> $1.30 | N/A | View details for HC Wainwright rating of Northern Dynasty Minerals (NYSEAMERICAN:NAK) on 2/4/2025 |
HALO Halozyme Therapeutics | $57.75
+0.5% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $70.00 -> $70.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 2/4/2025 |
ANAB AnaptysBio | $18.62
-1.3% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $19.00 -> $19.00 | High | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 2/4/2025 |
IVVD Invivyd | $1.77
+46.3% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 2/4/2025 |
TRDA Entrada Therapeutics | $13.04
-0.2% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | Medium | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 2/4/2025 |
VNDA Vanda Pharmaceuticals | $4.43
-1.3% | 2/4/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 2/4/2025 |
BCTX BriaCell Therapeutics | $4.46
-12.0% | 2/3/2025 | Target Raised by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $15.00 -> $32.00 | High | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 2/3/2025 |
TNYA Tenaya Therapeutics | $1.11
-1.8% | 2/3/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $18.00 -> $18.00 | Low | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 2/3/2025 |
BKSY BlackSky Technology | $16.68
-8.9% | 2/3/2025 | Target Raised by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $12.00 -> $20.00 | Medium | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 2/3/2025 |
XOMA XOMA | $23.52
-4.2% | 2/3/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $123.00 -> $104.00 | High | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 2/3/2025 |
ONCY Oncolytics Biotech | $0.73
-1.8% | 2/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 2/3/2025 |
BEAM Beam Therapeutics | $30.43
-8.2% | 2/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 2/3/2025 |
PLX Protalix BioTherapeutics | $2.39
-1.6% | 2/3/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $15.00 | Low | View details for HC Wainwright rating of Protalix BioTherapeutics (NYSE:PLX) on 2/3/2025 |
Important: case study on TGT (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
CRSP CRISPR Therapeutics | $47.91
-5.0% | 2/3/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $65.00 | Low | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/3/2025 |
VRTX Vertex Pharmaceuticals | $484.24
+0.8% | 1/31/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $535.00 -> $550.00 | High | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2025 |
VALN Valneva | $7.44
-5.9% | 1/31/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 1/31/2025 |
LCTX Lineage Cell Therapeutics | $0.68
-2.5% | 1/31/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 1/31/2025 |
MNMD Mind Medicine (MindMed) | $7.63
-6.7% | 1/31/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 1/31/2025 |
VIR Vir Biotechnology | $9.57
-2.3% | 1/31/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $110.00 -> $110.00 | Low | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 1/31/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 1/31/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 -> $190.00 | Medium | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/31/2025 |
ATOS Atossa Therapeutics | $0.80
-5.3% | 1/30/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 1/30/2025 |
IVA Inventiva | $2.84
+3.6% | 1/30/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 1/30/2025 |
MUX McEwen Mining | $7.16
-6.2% | 1/30/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $19.00 -> $18.00 | Low | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 1/30/2025 |
NDA Neptune Digital Assets | C$1.75
-4.4% | 1/30/2025 | Target Raised by | HC Wainwright | - | | C$2.00 -> C$3.00 | N/A | View details for HC Wainwright rating of Neptune Digital Assets (CVE:NDA) on 1/30/2025 |
KSCP Knightscope | $8.02
-5.4% | 1/30/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $16.00 | Medium | View details for HC Wainwright rating of Knightscope (NASDAQ:KSCP) on 1/30/2025 |
MAG MAG Silver | $15.76
-6.7% | 1/30/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $20.00 -> $21.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 1/30/2025 |
SRZN Surrozen | $11.20
-3.0% | 1/30/2025 | Initiated by | HC Wainwright | Analyst Matthew Caufield | Buy | $32.00 | High | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 1/30/2025 |
SRPT Sarepta Therapeutics | $106.28
-2.0% | 1/30/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/30/2025 |
GOSS Gossamer Bio | $1.40
-8.5% | 1/30/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 1/30/2025 |
SPRO Spero Therapeutics | $0.83
-0.7% | 1/30/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 1/30/2025 |
CING Cingulate | $4.33
+2.2% | 1/30/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $20.00 | High | View details for HC Wainwright rating of Cingulate (NASDAQ:CING) on 1/30/2025 |
PEPG PepGen | $1.37
-4.9% | 1/30/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $26.00 -> $16.00 | High | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 1/30/2025 |
CRGX CARGO Therapeutics | $3.77
+2.2% | 1/30/2025 | Downgraded by | HC Wainwright | Analyst Robert Burns | Buy -> Neutral | | N/A | View details for HC Wainwright rating of CARGO Therapeutics (NASDAQ:CRGX) on 1/30/2025 |
NNE Nano Nuclear Energy | $28.94
-5.5% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst S. Joshi | Buy -> Buy | $50.00 -> $50.00 | Low | View details for HC Wainwright rating of Nano Nuclear Energy (NASDAQ:NNE) on 1/29/2025 |
GAU Galiano Gold | $1.29
-2.3% | 1/29/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.10 -> $2.80 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 1/29/2025 |
SLN Silence Therapeutics | $4.79
-4.2% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 1/29/2025 |
CGEM Cullinan Therapeutics | $9.03
-1.3% | 1/29/2025 | Target Raised by | HC Wainwright | Analyst Edward White | Buy -> Buy | $28.00 -> $33.00 | High | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 1/29/2025 |
ZNTL Zentalis Pharmaceuticals | $2.32
-6.1% | 1/29/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $20.00 -> $10.00 | High | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 1/29/2025 |
USIO Usio | $1.71
-2.8% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Usio (NASDAQ:USIO) on 1/29/2025 |
TRNS Transcat | $79.85
-4.5% | 1/29/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $126.00 -> $106.00 | High | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 1/29/2025 |
HIVE HIVE Digital Technologies | $2.49
-7.4% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 1/29/2025 |
SABS SAB Biotherapeutics | $1.82
-6.7% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 1/29/2025 |
LXRX Lexicon Pharmaceuticals | $0.71
-2.2% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 1/29/2025 |
OPT Opthea | $5.02
+0.6% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Opthea (NASDAQ:OPT) on 1/29/2025 |
UNCY Unicycive Therapeutics | $0.62
+1.1% | 1/29/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 1/29/2025 |
NRIX Nurix Therapeutics | $16.87
-1.0% | 1/29/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $35.00 -> $36.00 | Medium | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 1/29/2025 |
LPTX Leap Therapeutics | $0.48
-0.5% | 1/29/2025 | Downgraded by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Neutral | | High | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 1/29/2025 |
PTN Palatin Technologies | $1.00
-2.0% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 1/28/2025 |
ATAI Atai Life Sciences | $1.99
-2.5% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 1/28/2025 |
CLSK CleanSpark | $9.25
-8.1% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $27.00 -> $27.00 | Medium | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 1/28/2025 |
FNV Franco-Nevada | $138.51
-2.3% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $155.00 -> $155.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 1/28/2025 |
RNAC Cartesian Therapeutics | $19.24
-1.9% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $45.00 -> $45.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 1/28/2025 |
AVXL Anavex Life Sciences | $8.35
-3.8% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | Medium | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
VNDA Vanda Pharmaceuticals | $4.43
-1.3% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | Low | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 1/28/2025 |
ATRA Atara Biotherapeutics | $7.11
-5.5% | 1/28/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | | High | View details for HC Wainwright rating of Atara Biotherapeutics (NASDAQ:ATRA) on 1/28/2025 |
CYBN Cybin | $9.09
-2.6% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $190.00 -> $190.00 | Low | View details for HC Wainwright rating of Cybin (NYSE:CYBN) on 1/27/2025 |
AKRO Akero Therapeutics | $51.84
+2.5% | 1/27/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $50.00 -> $72.00 | High | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 1/27/2025 |
RICK RCI Hospitality | $52.07
-2.8% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $98.00 -> $98.00 | Low | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 1/27/2025 |
HRMY Harmony Biosciences | $34.56
-0.9% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 1/27/2025 |
MIST Milestone Pharmaceuticals | $2.04
-1.0% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $25.00 | Low | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 1/27/2025 |
SGMO Sangamo Therapeutics | $1.07
-4.5% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 1/27/2025 |
IMCR Immunocore | $29.92
+0.2% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 -> $100.00 | Medium | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 1/27/2025 |
GHRS GH Research | $12.51
-10.7% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 1/27/2025 |
Important: case study on TGT (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
QURE uniQure | $12.84
-0.9% | 1/27/2025 | Target Raised by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $70.00 | Medium | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 1/27/2025 |
VYGR Voyager Therapeutics | $4.22
-0.9% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 1/27/2025 |
PSNL Personalis | $4.72
-13.1% | 1/27/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.00 -> $8.00 | Medium | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 1/27/2025 |
BCAX Bicara Therapeutics | $13.00
-5.9% | 1/27/2025 | Target Raised by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $42.00 -> $45.00 | Medium | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 1/27/2025 |
ADAG Adagene | $2.10
+2.9% | 1/27/2025 | Target Raised by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $5.00 -> $8.00 | High | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 1/27/2025 |
EXEL Exelixis | $36.85
+5.0% | 1/27/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 1/27/2025 |
LYTS LSI Industries | $19.29
-4.2% | 1/24/2025 | Target Raised by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $20.00 -> $30.00 | High | View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 1/24/2025 |
LRMR Larimar Therapeutics | $3.19
-2.4% | 1/24/2025 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 1/24/2025 |
ALXO ALX Oncology | $1.12
-0.4% | 1/24/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $5.00 | High | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 1/24/2025 |
MBOT Microbot Medical | $1.61
-6.1% | 1/24/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $9.00 | Medium | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 1/24/2025 |
LEXX Lexaria Bioscience | $1.45
+1.4% | 1/24/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $10.00 -> $7.00 | High | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 1/24/2025 |
VIGL Vigil Neuroscience | $3.03
+4.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $17.00 -> $17.00 | High | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 1/23/2025 |
ATXS Astria Therapeutics | $6.81
-0.1% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 1/23/2025 |
AKBA Akebia Therapeutics | $1.80
-5.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 1/23/2025 |
ETON Eton Pharmaceuticals | $14.49
+0.7% | 1/23/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $17.00 -> $33.00 | High | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 1/23/2025 |
SMTI Sanara MedTech | $33.69
-4.6% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 1/23/2025 |
WKSP Worksport | $0.79
-3.2% | 1/23/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $1.50 | Medium | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 1/23/2025 |
RGEN Repligen | $158.99
-2.3% | 1/23/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $240.00 -> $180.00 | Low | View details for HC Wainwright rating of Repligen (NASDAQ:RGEN) on 1/23/2025 |
GMAB Genmab A/S | $22.34
-0.4% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $50.00 -> $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 1/23/2025 |
ARWR Arrowhead Pharmaceuticals | $19.90
-5.1% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 1/23/2025 |
NUVB Nuvation Bio | $2.21
-2.9% | 1/23/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $10.00 -> $11.00 | High | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 1/23/2025 |
ESPR Esperion Therapeutics | $1.83
-1.4% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 1/23/2025 |
VALN Valneva | $7.44
-5.9% | 1/23/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $19.00 -> $18.00 | High | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 1/23/2025 |
PGEN Precigen | $1.91
-3.0% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $4.00 -> $6.00 | High | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 1/23/2025 |
CHRS Coherus BioSciences | $1.07
-2.7% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 1/23/2025 |
EXOD Exodus Movement | $47.81
+0.0% | 1/23/2025 | Initiated by | HC Wainwright | Analyst Kevin Dede | Buy | $50.00 | N/A | View details for HC Wainwright rating of Exodus Movement (NYSEAMERICAN:EXOD) on 1/23/2025 |
RIGL Rigel Pharmaceuticals | $20.09
-3.6% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $57.00 -> $57.00 | Medium | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 1/22/2025 |
ALT Altimmune | $6.43
-3.0% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 1/22/2025 |
RVPH Reviva Pharmaceuticals | $1.57
-3.7% | 1/22/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $14.00 -> $11.00 | High | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/22/2025 |
CAN Canaan | $1.67
-6.7% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 1/22/2025 |
ASM Avino Silver & Gold Mines | $1.36
-7.5% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.80 -> $1.90 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/22/2025 |
ASM Avino Silver & Gold Mines | $1.38
+1.9% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.80 -> $1.90 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/22/2025 |
DRD DRDGOLD | $11.05
-5.1% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $13.25 -> $17.25 | High | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 1/22/2025 |
EOLS Evolus | $13.99
-4.3% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 1/22/2025 |
RDW Redwire | $17.90
-10.5% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $18.00 -> $26.00 | Medium | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 1/22/2025 |
IPSC Century Therapeutics | $0.73
-2.5% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 1/22/2025 |
MNPR Monopar Therapeutics | $40.25
-1.8% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $22.00 -> $40.00 | Medium | View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 1/22/2025 |
AGEN Agenus | $3.32
-3.8% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 1/22/2025 |
REPL Replimune Group | $13.98
-2.3% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $17.00 -> $21.00 | High | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 1/22/2025 |
AVBP ArriVent BioPharma | $27.07
-1.2% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $36.00 -> $39.00 | High | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 1/22/2025 |
ATRA Atara Biotherapeutics | $7.11
-5.5% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | | High | View details for HC Wainwright rating of Atara Biotherapeutics (NASDAQ:ATRA) on 1/22/2025 |
COCP Cocrystal Pharma | $1.95
-0.5% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 1/22/2025 |
CYTK Cytokinetics | $50.26
-1.7% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 1/21/2025 |
IRON Disc Medicine | $54.52
+0.3% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $118.00 -> $118.00 | Medium | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 1/21/2025 |
TLPH Talphera | $0.60
-1.9% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 1/21/2025 |
ABUS Arbutus Biopharma | $3.42
-0.5% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/21/2025 |
ETNB 89bio | $11.08
+1.0% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 1/21/2025 |
SMMT Summit Therapeutics | $22.12
-4.1% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $44.00 -> $44.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 1/21/2025 |
LEGN Legend Biotech | $39.70
+2.0% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $73.00 -> $73.00 | High | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 1/21/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 -> $180.00 | High | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/21/2025 |
VNDA Vanda Pharmaceuticals | $4.43
-1.3% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 1/21/2025 |
AVXL Anavex Life Sciences | $8.35
-3.8% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | High | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/21/2025 |
EBS Emergent BioSolutions | $7.74
-1.3% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 1/21/2025 |
VRNA Verona Pharma | $67.96
+5.9% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $60.00 | High | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 1/21/2025 |
VKTX Viking Therapeutics | $34.07
+7.7% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 1/17/2025 |
CECO CECO Environmental | $23.00
-4.8% | 1/17/2025 | Downgraded by | HC Wainwright | Analyst Amit Dayal | Buy -> Neutral | | High | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 1/17/2025 |
OTLK Outlook Therapeutics | $1.56
-4.9% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/17/2025 |
CABA Cabaletta Bio | $2.05
-2.2% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 1/17/2025 |
NUVL Nuvalent | $79.49
-3.5% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $110.00 -> $110.00 | Low | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 1/17/2025 |
ABSI Absci | $4.96
-4.5% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 1/17/2025 |
